Cervical ripening agents and uterine stimulants

Michael L. Stitely, Andrew Satin

Research output: Contribution to journalArticle

Abstract

The discussion of drugs for uterine stimulation is divided into discussion of labor induction versus labor augmentation. Use of cervical ripening agents for the induction of the unfavorable cervix has led to less failed inductions (Fig. 1). Misoprostol and dino-prostone are the most widely used pharmacologic agents for cervical repining. Oxytocin remains the only agent supported by a plethora of data for stimulation of uterine activity after the patient enters active labor. As cited above, a wide variety of acceptable dosing regimens exists. A common finding in comparing various uterine stimulants is more aggressive dosing regimens may reduce time in labor, but may increase the incidence of uterine hyperstimulation. The stimulation of labor with a viable fetus regardless of the agent or regimen requires monitoring of mother and fetus and the ability to promptly perform a cesarean if uterine stimulation is not tolerated by the fetus.

Original languageEnglish (US)
Pages (from-to)114-124
Number of pages11
JournalClinical Obstetrics and Gynecology
Volume45
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Oxytocics
Cervical Ripening
Induced Labor
Fetus
Misoprostol
Aptitude
Oxytocin
Cervix Uteri
Mothers
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cervical ripening agents and uterine stimulants. / Stitely, Michael L.; Satin, Andrew.

In: Clinical Obstetrics and Gynecology, Vol. 45, No. 1, 2002, p. 114-124.

Research output: Contribution to journalArticle

Stitely, Michael L. ; Satin, Andrew. / Cervical ripening agents and uterine stimulants. In: Clinical Obstetrics and Gynecology. 2002 ; Vol. 45, No. 1. pp. 114-124.
@article{bb3e086907564650a15d6354775d469b,
title = "Cervical ripening agents and uterine stimulants",
abstract = "The discussion of drugs for uterine stimulation is divided into discussion of labor induction versus labor augmentation. Use of cervical ripening agents for the induction of the unfavorable cervix has led to less failed inductions (Fig. 1). Misoprostol and dino-prostone are the most widely used pharmacologic agents for cervical repining. Oxytocin remains the only agent supported by a plethora of data for stimulation of uterine activity after the patient enters active labor. As cited above, a wide variety of acceptable dosing regimens exists. A common finding in comparing various uterine stimulants is more aggressive dosing regimens may reduce time in labor, but may increase the incidence of uterine hyperstimulation. The stimulation of labor with a viable fetus regardless of the agent or regimen requires monitoring of mother and fetus and the ability to promptly perform a cesarean if uterine stimulation is not tolerated by the fetus.",
author = "Stitely, {Michael L.} and Andrew Satin",
year = "2002",
doi = "10.1097/00003081-200203000-00012",
language = "English (US)",
volume = "45",
pages = "114--124",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cervical ripening agents and uterine stimulants

AU - Stitely, Michael L.

AU - Satin, Andrew

PY - 2002

Y1 - 2002

N2 - The discussion of drugs for uterine stimulation is divided into discussion of labor induction versus labor augmentation. Use of cervical ripening agents for the induction of the unfavorable cervix has led to less failed inductions (Fig. 1). Misoprostol and dino-prostone are the most widely used pharmacologic agents for cervical repining. Oxytocin remains the only agent supported by a plethora of data for stimulation of uterine activity after the patient enters active labor. As cited above, a wide variety of acceptable dosing regimens exists. A common finding in comparing various uterine stimulants is more aggressive dosing regimens may reduce time in labor, but may increase the incidence of uterine hyperstimulation. The stimulation of labor with a viable fetus regardless of the agent or regimen requires monitoring of mother and fetus and the ability to promptly perform a cesarean if uterine stimulation is not tolerated by the fetus.

AB - The discussion of drugs for uterine stimulation is divided into discussion of labor induction versus labor augmentation. Use of cervical ripening agents for the induction of the unfavorable cervix has led to less failed inductions (Fig. 1). Misoprostol and dino-prostone are the most widely used pharmacologic agents for cervical repining. Oxytocin remains the only agent supported by a plethora of data for stimulation of uterine activity after the patient enters active labor. As cited above, a wide variety of acceptable dosing regimens exists. A common finding in comparing various uterine stimulants is more aggressive dosing regimens may reduce time in labor, but may increase the incidence of uterine hyperstimulation. The stimulation of labor with a viable fetus regardless of the agent or regimen requires monitoring of mother and fetus and the ability to promptly perform a cesarean if uterine stimulation is not tolerated by the fetus.

UR - http://www.scopus.com/inward/record.url?scp=0036192566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036192566&partnerID=8YFLogxK

U2 - 10.1097/00003081-200203000-00012

DO - 10.1097/00003081-200203000-00012

M3 - Article

C2 - 11862063

AN - SCOPUS:0036192566

VL - 45

SP - 114

EP - 124

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 1

ER -